Health-related quality of life in patients with metastatic Merkel cell carcinoma receiving second-line or later avelumab treatment: 36-month follow-up data-MedSci.cn

Health-related quality of life in patients with metastatic Merkel cell carcinoma receiving second-line or later avelumab treatment: 36-month follow-up data

D'Angelo, SP; Nolte, S; Schlichting, M; Henry-Szatkowski, M; Hennessy, M; Bharmal, M

ANNALS OF ONCOLOGY, 2019; 30 (): 538

科室
- - 订阅+
  - 更多科室
工具
服务